DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced U.S. Food and Drug Administration (FDA) 510(k) ...
New addition to Baxter’s Evo IQ Infusion Platform complements on-market large volumetric pump, offering opportunity to further help personalize treatment Incorporates web-based Dose IQ Safety Software ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results